July 1, 2016
Recommended Topic Related To:

Luzu

"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...

A A A

Luzu

Overdosage
Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

None.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 6/27/2016

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.